Zydus Lifesciences receives tentative FDA approval for generic Azilsartan Medoxomil tablets for high blood pressure.
Zydus Lifesciences has received tentative approval from the US FDA for its generic Azilsartan Medoxomil tablets, used to treat high blood pressure. The FDA approved 40 mg and 80 mg strengths of the medication, which is used to lower blood pressure and reduce the risk of fatal and nonfatal cardiovascular events. The drug had annual sales of USD 89 million in the US, according to IQVIA data from March 2024.
July 04, 2024
3 Articles